Amy C. Moore, Director of Patient Engagement and Advocacy at Summit Therapeutics, Inc., shared LUNG CONNECT powered by COR2E’s post on LinkedIn, adding:
“Proud to have been part of this team that assessed patient understanding of biomarker testing in NSCLC.”
Quoting LUNG CONNECT powered by COR2ED’s post:
“Survey results published: Patient understanding of biomarker testing in non-small cell lung cancer (NSCLC)
We surveyed patients and caregivers to assess awareness, knowledge, and attitudes surrounding biomarker testing in NSCLC
The results highlight gaps we can address to better support shared decision-making
Video summary in this post.
Download the Blueprint for full details/results PLUS a patient infographic to use in your clinic.
From Christian Rolfo, Fernando Lopez-Rios, and Dr Rodrigo Paredes.
Made in collaboration with patient advocacy experts Anne-Marie Baird, Amy C. Moore and Shani Shilo.
This programme is endorsed by LUNGevity, The Israeli Lung Cancer Foundation, NTRKers and Biomarker Collaborative. This educational programme is supported by an Independent Educational Grant from Bayer.”
Title: Biomarker testing in non-small cell lung cancer (NSCLC)
Authors: Christian Rolfo, Fernando López-Ríos, Rodrigo Paredes de la Fuente, Anne-Marie Baird, Amy C. Moore, Shani Shilo
Read the full article.
You can also read:
